Clay Siegall
Board Member at Shattuck Labs
Clay Siegall is President and CEO at Immunome, Inc. and serves as a Board Member at Shattuck Labs. He previously founded Seagen, which was acquired, and has held leadership roles at Morphimmune, Seagen, and Tourmaline Bio.
Recent coverage
Front-page news, podcasts and videos about Clay
GeekWire Week in Review (May 14, 2023): Top stories include ex-CFO indicted over $35M crypto transfer, Bezos’ $500M yacht, and Amazon legal/personnel news
GeekWire's Week in Review for May 14, 2023 lists the site's most-read stories, including a Seattle startup ex-CFO indicted over an alleged $35M crypto transfer, Jeff Bezos' $500M yacht, and Amazon-related legal and personnel news.
Organizations
See all 5-
Shattuck Labs Board Member 2024–present · current
-
Immunome President and CEO 2023–present, CEO and President · current
-
Seagen President and CEO 1998–2022, Co-founder 2022, Former CEO 2022 · current
Education
-
The George Washington University Doctor of Philosophy - PhD, Genetics
-
University of Maryland Bachelor of Science - BS, Zoology
